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This bird’s eye view from the 2015 European
Society of Cardiology (ESC) congress hosted in London
from August 29 to September 2 includes highlighted
abstracts on multimodality imaging. At this ESC meet-
ing, 407 imaging abstracts (40% of abstracts submitted
under the topic of imaging) were presented. Four experts
on echocardiography (VD), cardiac computed tomogra-
phy (CT) (SA), cardiac magnetic resonance (CMR)
(US), and nuclear imaging (JK) summarized 4 to 7
abstracts in these areas that were of most interest to
them. These abstracts were integrated by one of the
Editors of the Journal (JB).
ECHOCARDIOGRAPHY
Speckle tracking echocardiography (STE) continues
providing novel insights into cardiac mechanics and
prognosis. The Berliner Frauen Risiko evaluation study
assessed the association between left atrial (LA) reser-
voir, conduit and booster pump functions measured with
STE and left ventricular (LV) diastolic dysfunction
grade in 449 women.1 Strain-derived reservoir and
conduit functions reduced in parallel to worsening
diastolic dysfunction, whereas LA booster pump func-
tion increased in grade 1 diastolic dysfunction, and
subsequently decreased in grade 2 and 3 diastolic
dysfunction. Compared with LA volume index, strain-
derived reservoir and conduit functions showed higher
sensitivity (73.7% and 87.2%, respectively) and speci-
ficity (80.4% and 75.8%, respectively) to predict LV
diastolic dysfunction. These results suggest that changes
in LA functions assessed with STE may precede LA
remodeling in the early phases of LV diastolic function.
Early diagnosis of arrhythmogenic right ventricular
dysplasia (ARVD) using STE was the objective of the
study presented by Teske and coworkers.2 The electro-
mechanical interval, defined as the time difference
between first ECG-detected deflection of the QRS
complex and the onset of shortening of the basal, mid,
and apical segments of the right ventricular (RV) free
wall, was measured as a surrogate of activation delay in
44 mutation-positive ARVD patients, 31 mutation car-
riers without phenotype of ARVD, and 30 healthy
controls. The electro-mechanical interval was associated
with the occurrence of ventricular tachyarrhythmias.
From the healthy controls, a cut-off value[100 ms was
derived to define an abnormal electro-mechanical inter-
val. Mutation-positive ARVD patients had an abnormal
electro-mechanical interval in all RV segments, whereas
only 55% of mutation carriers without ARVD phenotype
showed an abnormal electro-mechanical interval in the
basal RV segment. After a median follow-up of
3.8 ± 2.8 years, patients of the mutation-positive and
the mutation carriers without phenotype of ARVD
groups with an abnormal electro-mechanical interval at
the basal segment of the RV free wall showed a
significantly higher burden of ventricular arrhythmias.
The results of a sub-study from the EchoCRT trial
(Cardiac resynchronization therapy in heart failure with
narrow QRS complex) were presented, focusing on the
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prognostic implications of persistent or worsened LV
dyssynchrony after CRT implantation.3 Of 614 patients
with echocardiographic follow-up at 6 months after
CRT implantation, 77% showed persistent or worsened
LV dyssynchrony (C130 ms as measured with STE or
C80 ms using tissue Doppler imaging). Patients with
persistent or worsened LV dyssynchrony showed a
significantly increased risk of all-cause mortality and
heart failure hospitalization (hazard ratio 1.54, 95%
confidence interval 1.03-2.30; P = .02) compared with
patients with reduced LV dyssynchrony, confirming
observational results in heart failure patients with wide
QRS complex.4
Three-dimensional transthoracic echocardiography
(3D TTE) attracts significant attention. Tricuspid valve
regurgitation in patients with RV pacing leads has poor
prognosis.5 In 145 patients with pacemaker or
implantable cardioverter defibrillator (ICD), the mobility
of the RV pacing lead and its position relative to the
tricuspid valve annulus was assessed with 3D TTE. At
follow-up after device implantation, 30% presented with
grade 3 or more tricuspid regurgitation. Patients were
classified as having low risk for significant tricuspid
regurgitation if the lead was freely mobile without
interfering with the leaflet movement and positioned in
the center of the tricuspid valve annulus or in the
commissure of the tricuspid leaflets. In contrast, patients
with high risk of developing significant tricuspid regur-
gitation had more frequently fixed leads interfering with
leaflet mobility and more frequently showed leaflet
perforation. Three-dimensional analysis of the tricuspid
valve and the underlying pathophysiology of tricuspid
regurgitation may help to personalize treatment of
patients with symptomatic severe tricuspid regurgitation.
The use of dedicated software to create a 3D model that
can subsequently be printed may help to decide on the
repair approach. Muraru and coworkers presented the first
3D printed model of the tricuspid valve.6 Coordinates of
the tricuspid annulus and leaflets were imported into
Mesh-Lab (Visual Computing Lab ISTI-CNR) software
to build a model which was converted to stereolitho-
graphic file format and printed in 3D in 30 minutes
(Figure 1). The 3D printed tricuspid valve permitted
better perception of the complex 3D geometry.
COMPUTED TOMOGRAPHY
In cardiac CT, most of the presented research at the
ESC Congress 2015 was in relation to clinical applica-
tions, and relatively few abstracts concerned new
technical developments. The use of ‘‘virtual’’ fractional
flow reserve, derived from the anatomic information
provided by coronary CT angiography (CTA), received
most attention. The PLATFORM study7 was designed to
evaluate the utility of coronary CTA with fractional flow
reserve (FFR-CT) to serve as a ‘‘gatekeeper’’ for
invasive angiography. A total of 584 patients with new
onset chest pain were recruited in 11 centers in Europe,
with core laboratory evaluation in the United States. The
patients were divided in 2 cohorts: a ‘‘non-invasive
workup first’’ cohort of 204 individuals, and a ‘‘planned
invasive angiography’’ cohort of 380 patients, depend-
ing on the management planned by the treating
physician. In both cohorts, patients were randomized
to either the originally planned test, or to coronary CTA
with FFR-CT (in the presence of 30% or more luminal
stenosis). The primary outcome measure was the rate of
invasive coronary angiograms that did not show obstruc-
tive disease in the cohort that had been planned to
undergo invasive angiography. Indeed, the use of
coronary CTA (plus FFR-CT in 117 cases) resulted in
a rate of invasive coronary angiograms showing no
stenosis of 12.4% (24/193), as compared to 73.3% (137/
187) in those who underwent the initially planned
invasive angiogram directly, without prior CT. In the
cohort of 204 patients for whom a non-invasive workup
Figure 1. Three-dimensional printing of the tricuspid valve. From three-dimensional transthoracic
echocardiographic data of the tricuspid valve, coordinates of the leaflets and annulus are
demarcated (A) and imported to dedicated software to create the model (B) which is converted to
stereolithographic file format and printed in 3D (C). Reproduced with permission from Muraru
et al6.
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was initially planned, there was no significant difference
in the rate of invasive angiograms showing no stenoses
(6.0% without CTA/FFR-CT vs. 12.5% with CTA/FFR-
CT, P = .95). However, this was not a primary outcome
measure. Average radiation exposure was not increased
by the use of CTA/FFR-CT in either cohort. Ninety-day
major adverse cardiac event (MACE) rates were not
increased in those patients who underwent CTA rather
than invasive angiography. All in all, the study reassur-
ingly showed that CTA/FFR-CT can reduce the number
of unnecessary invasive angiograms, and specifically
reduce the number of angiograms showing no stenosis,
in patients with suspected coronary disease—hence well
serving its ‘‘gatekeeper’’ role.
Numerous abstracts dealt with the prognostic value
of coronary CTA. Bom et al evaluated 1551 patients
with low-to-intermediate risk of coronary artery disease
who underwent coronary CTA as well as calcium
scoring.8 During a median follow-up of 637 days, 23
patients (1.5%) experienced an event: late revascular-
izations (16/23), myocardial infarction (4/23), and death
(3/23). Both coronary calcium scoring and coronary
CTA had prognostic value. The multivariable analysis,
adjusting for risk factors and coronary calcium score,
demonstrated an independent prognostic value of coro-
nary CTA (Figure 2).
Marwan et al reported the results of the German
cardiac CT registry regarding the presence of coronary
artery lesions in coronary CTA of 2016 individuals
without coronary calcium.9 In 18% of these individuals,
non-obstructive coronary lesions and in 2.3%, obstruc-
tive lesions were found, emphasizing that coronary
atherosclerosis can occur even in patients without
coronary calcium.
An increasingly important area is the use of cardiac
CT for non-coronary interventions, for example, in heart
valve disease. Fonseca et al presented a series of 131
patients who underwent transcatheter aortic valve
implantation with a balloon-expandable (36%) or self-
expanding (64%) prosthesis.10 53% of patients had
paravalvular regurgitation after the procedure, which
was mild in 46% and moderate in 8%. Aortic valve
calcium was predictive of post-implant regurgitation,
with an optimal cut-off value of 157 mm3 of calcium
measured with a lower threshold of 850 HU to accept a
structure as ‘‘calcium.’’ The degree of aortic valve
calcification (optimum cut-off: 267 mm3) was also a
predictor for the need to perform balloon post-dilatation.
Mitral valve interventions may also profit from CT
imaging. In 25 patients planned for edge-to-edge mitral
valve repair, CTA and transesophageal echocardiogra-
phy showed excellent agreement regarding parameters
such as leaflet length, annulus diameters, and left
ventricular dimensions.11 Finally, CT imaging is impor-
tant in patients considered for transcatheter LA
appendage occlusion, and CT may be the preferred
method for assessment of mean diameter of the LA
appendage orifice.12
Figure 2. Major adverse cardiac event (MACE)-free survival in a cohort of 1551 patients
with chest pain and a low-to-intermediate pre-test probability for coronary artery disease
followed for a median of 637 days. A total of 23 MACE occurred, in the majority late
revascularizations (n = 16). Left prognostic value of the calcium score, right prognostic
value of coronary computed tomography angiography (CTA). In multivariable analysis,
obstructive plaque in coronary CTA added significantly to the calcium score and risk factors.
CACS, coronary artery calcium score; CCTA, coronary computed tomography angiography.
Reproduced with permission from Bom et al8.
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CARDIAC MAGNETIC RESONANCE IMAGING
Important topics in research with cardiac magnetic
resonance (CMR) at the ESC Congress 2015 included
assessment of diffuse myocardial fibrosis, advanced
diagnosis of coronary artery disease, and risk stratifica-
tion for ICD implantation.
Validation of pre-contrast T1 mapping values and
myocardial extracellular volume measurement with
CMR techniques as surrogates of interstitial diffuse
fibrosis was the objective of several studies including
patients with different cardiomyopathies.13-15 In patients
with dilated cardiomyopathy, longer pre-contrast T1
mapping values were significantly correlated with larger
amounts of extracellular volume and larger histological
collagen volume fraction, indicating more extensive LV
fibrosis.14,15 In addition, in 531 consecutive patients
referred for CMR for other reasons than hypertrophic
cardiomyopathy, Kammerlander et al showed that
increasing myocardial extracellular volume was inde-
pendently associated with increased risk of heart failure
hospitalization and cardiovascular death.13 In patients
with acute ST-segment elevation myocardial infarction,
magnitude and changes in myocardial extracellular
volume (assessed with T1 mapping) in areas remote
from the infarct core, were associated with changes in
LV ejection fraction (EF).16 In 171 ST-segment eleva-
tion myocardial infarction patients, extracellular volume
of the remote area at baseline (2 days after index
infarction) and at 6 months follow-up did not change
significantly (from 25.6 ± 3.1% to 25.5 ± 2.8%),
whereas LVEF increased from 55.6 ± 9.3% to 62.7 ±
9.4%. A change in extracellular volume was inversely
associated with a change in LVEF (r = -0.23; P =
.011). Moreover, an increase in extracellular volume of
the remote area of C1% at 6 months follow-up was
observed in 43% of patients.17 Compared with patients
in whom extracellular volume did not change, patients
with increased extracellular volume showed ‘‘higher
risk’’ characteristics: older age, higher peak troponin,
more frequent microvascular obstruction and reduced
LVEF, and larger LV volumes at follow-up. This work
demonstrates that the adverse process of LV remodeling
post-ST-segment elevation myocardial infarction can be
detected and quantified non-invasively with CMR.
Coronary microvascular disease is characterized by
angina, positive tests for ischemia, and the absence of
epicardial coronary stenoses. CMR can be useful in these
patients to determine coronary flow reserve by measuring
coronary sinus flow at rest and during pharmacologic
stress, and then myocardial perfusion reserve is calculated
as the ratio between stress coronary sinus flow/baseline
coronary sinus flow in 245 consecutive patients. Patients
with a myocardial perfusion reserve below or equal to the
mean (2.75) had worse outcome compared to patients with
preserved myocardial perfusion reserve ([2.75).18 Fur-
thermore, patients with microvascular dysfunction often
experience resting chest pain due to concomitant
microvascular spasm. Coronary spasm including
microvascular spasm can be provoked by intracoronary
acetylcholine. This test revealed microvascular spasm in
59 out of 125 patients, whereas epicardial spasm was
elicited in 28 of 125 patients.19 Stress CMR showed a
reversible adenosine-induced subendocardial perfusion
defect in 58 out of these 125 patients (Figure 3).
Patients with dilated cardiomyopathy and
LVEF\35% are candidates for ICD implantation as
primary prevention of sudden cardiac death. The incre-
mental prognostic value of LVEF and the presence of
myocardial scar assessed with CMR were evaluated in
270 patients with dilated cardiomyopathy.20 During
2.5 years of follow-up, 68 presented with ventricular
tachyarrhythmias and sudden cardiac death. Patients
with events had lower LVEF (29 ± 10 vs. 32 ± 9%,
P = .003) and higher frequency of myocardial scar (67
vs. 44%, P = .0009) than patients who did not present
with events.
In addition, an interesting multicenter trial studied
whether the extent and heterogeneity of late gadolinium
enhancement (LGE) areas (identifying the infarct border
zone) predicted appropriate ICD therapy in 55 patients
with ischemic cardiomyopathy and 62 with dilated
cardiomyopathy.21 During a mean follow-up of 4 years,
patients with larger (above the median) compared to
smaller border zones had higher rates of ICD therapy,
whereas total LGE burden was similar between groups
with and without ICD therapy. The importance of the
size of the border zone surrounding the scar was
confirmed in another study of 138 ST-segment elevation
myocardial infarction patients who were studied by
CMR within 1 week post-infarction.22 In a multivariate
model that included clinical and other established
prognostic parameters, the extent of the border zone
was an independent predictor of the combined clinical
endpoint (all-cause death, re-infarction, new congestive
heart failure within 1 year of infarction). Thus, border
zone size may be a marker for risk stratifying patients
eligible for primary prevention ICD therapy.
NUCLEAR CARDIOLOGY
In nuclear cardiology, not only a large fraction of
abstracts focused on coronary artery disease and
myocardial perfusion imaging (MPI) but also other
methods such as innervation imaging gained increasing
attention.
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Al-Mallah et al23 investigated the incremental
prognostic significance of coronary flow reserve in
2645 consecutive patients with known or suspected
coronary artery disease using positron emission tomog-
raphy (PET, stress, and rest) and rubidium-82. During a
median follow-up of 1.4 years, data on cardiac death or
myocardial infarction were collected. The lowest tertile
of coronary flow reserve (\1.8) was associated with a
3.7-fold increase in the risk of events, as compared with
the highest tertile. This remained significant after
adjusting for clinical variables, perfusion defect size,
and resting LVEF. The study further emphasizes the
clinical value of absolute quantification of myocardial
perfusion and perfusion reserve over standard visual
assessment.
The prognostic value of single-photon emission
computed tomography (SPECT) MPI was addressed in
564 patients who were evaluated for renal transplanta-
tion.24 During a median follow-up of 43.5 months, 122
patients died (9.6% of cardiovascular causes). Compared
with patients without ischemia, patients with mild
(5-10% of the LV myocardium) and with substantial
ischemia ([10%) showed a significantly increased
mortality risk (respective hazard ratios: 2.27 and 2.44).
However, patients with substantial ischemia had lower
risk for cardiovascular death than patients with mild
ischemia, possibly because of more frequent
revascularizations.
The detection of vulnerable plaques using non-
invasive imaging has gained a lot of interest over the
Figure 3. Stress CMR to assess microvascular disease. Example of a 72-year-old woman
with angina complaints during rest and negative troponin. After reaching a peak exercise of
75 W during electrocardiogram stress testing, the patient developed chest pain. There was a
ST-segment depression in I, II, aVF, V4 to V6 leads. CMR showed circular subendocardial
hypoenhancement during adenosine stress (A, arrows). Perfusion at rest was normal (B).
Acetylcholine testing at 100 lg showed diffuse mild constriction of the epicardial left
coronary artery (C) which was accompanied by ST-segment depression in V1 to V3 leads.
Following nitroglycerin injection into the left coronary artery, the epicardial coronary artery
appeared wider (D) and ST-segment abnormalities resolved. Reproduced with permission
from Ong et al19.
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Figure 4. Combination of fibrosis imaging by cardiac magnetic resonance (CMR) (A) and late
and I-123-iodine metaiodobenzylguanidine (MIBG) uptake (B) and outcomes (C): patients with
larger amount of late gadolinium enhancement (LGE) on CMR and lower MIBG uptake on
SPECT have worse prognosis than the other groups of patients. Reproduced with permission from
Garcı´a-Gonza´lez et al26.
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recent years. PET imaging using F-18-fluorodeoxyglu-
cose (FDG) has been used in numerous studies to detect
vascular inflammation in the aorta and carotid arteries.
Recently, studies have used FDG and F-18-fluoride to
detect active plaques in human coronary arteries.
Locorotondo et al25 compared the characteristics of
unstable coronary artery plaques detected by intracoro-
nary optical coherence tomography and FDG PET
imaging in 20 consecutive patients with single-vessel
coronary artery disease. Coronary FDG uptake was
enhanced in patients with non-ST-elevation acute coro-
nary syndrome as compared to patients with
stable coronary artery disease, with a trend toward
higher activity in patients with inflamed thin cap fibro-
atheromas. The majority of patients (88%) without
inflamed thin cap fibro-atheromas and low FDG uptake
had stable coronary artery disease, while all patients
with inflamed thin cap fibro-atheromas and high FDG
uptake had non-ST-elevation acute coronary syndrome
suggesting that FDG uptake in plaques is associated with
inflammation and vulnerability.
Several studies focused on cardiac innervation
imaging using SPECT and I-123-iodine metaiodobenzyl-
guanidine (MIBG) or PET with [11C]hydroxyephedrine
(HED). Garcia Gonzalez et al26 performed scar imaging
with CMR and planar MIBG imaging in 86 heart failure
patients who were referred for ICD implantation. The
endpoints included appropriate ICD shocks, ventricular
tachycardia, and cardiac death; 19 patients (22%) reached
the endpoint. These patients had larger scar areas on late
gadolinium enhancement (LGE C9.13%) and reduced
MIBG uptake (heart to mediastinum ratio B1.32). The
combination of LGE CMR and MIBG imaging improved
the risk stratification (Figure 4).
Exercise training has beneficial effects in heart
failure patients. Valborgland et al evaluated whether
cardiac MIBG uptake would improve after 3 months of
exercise training.27 The study enrolled 23 patients who
were randomized to regular exercise, continuous train-
ing, and interval training. All patients underwent MIBG
imaging before and after the training period. The authors
reported no differences between the groups, suggesting
that alterations in sympathetic innervation are not
related to the beneficial effects of exercise training in
heart failure patients.
Finally, the effect of beta-blocker therapy on
cardiac sympathetic nerve function in patients with
idiopathic pulmonary arterial hypertension was studied
by Rijnierse et al.28 Patients with pulmonary arterial
hypertension and right ventricular failure are known to
suffer from impaired cardiac sympathetic innervation,
which may be related to the severity of the disease. The
authors investigated 18 patients with pulmonary hyper-
tension using [11C]HED PET in a prospective, double-
blind placebo-controlled crossover trial. A heteroge-
neous pattern of sympathetic nerve dysfunction was
noted, particularly in the right ventricle and septum.
Beta-blocker therapy resulted in increased septum and
right ventricle [11C]HED uptake, suggesting a positive
effect on regional neuronal remodeling.
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